 Efficacy ivermectin control microfilaremia treatment diethylcarbamazine II Immunologic changes treatment effect single dose ivermectin standard course diethylcarbamazine DEC several parameters host antifilarial immune response patients bancroftian filariasis double-blind drug trial participants measurable serum levels antifilarial antibodies parasite antigens onset study Drug-induced clearance microfilaremia temporary increase HC antigenemia decrease serum levels antibodies soluble filarial antigens Antigenemia patients amicrofilaremic treatment persons recurrent microfilaremia Treatment sustained increase serum levels tumor necrosis factor patients ivermectin DEC antiparasite activity different mechanisms pattern serologic changes patients drug